Injectables explained: toxins, fillers, skin boosters and biostimulators

Botulinum toxin products reduce signalling between nerves and selected muscles. In aesthetics they are commonly used for dynamic expression lines and, in some cases, muscle contouring. The effect depends on dose, injection point and individual anatomy.

Two practical points are worth knowing. The effect is not immediate — it develops over several days and is usually assessed at around two weeks, which is when any adjustment is appropriate. And it is temporary, typically lasting a few months, which is a safety feature as much as a limitation: an unsatisfactory result resolves on its own.

HA fillers are gel-like materials used to restore or modify facial volume and contour. Different products have different firmness, cohesivity and lifting capacity, so a product selected for lips may not be appropriate for deep structural support.

That reversibility is the most underrated advantage in the whole injectable field. It means a poor aesthetic outcome can be corrected, and more importantly that a vascular complication has an immediate treatment. It is a legitimate reason to prefer HA for a first treatment or an anatomically demanding area.

Longevity varies more than most people expect. Some filler persists considerably longer than the marketed duration — imaging studies have found material years after treatment — which matters when planning repeat sessions. Topping up on a fixed schedule without assessing what remains is a common route to gradual over-filling.

Skin boosters are generally used more superficially and are intended to improve hydration or skin quality rather than create major structural volume. HA-based boosters, polynucleotide/PDRN products and other formulations should not be assumed to behave identically.

For a fuller comparison of the categories, see our guide to how skin booster types differ.

Materials such as PLLA, PCL and CaHA are used with the aim of stimulating collagen and improving tissue structure over time. Some formulations provide an immediate carrier effect, but the longer-term result develops gradually.

These materials are not simply interchangeable with HA filler and often require more conservative planning because they are not routinely reversed in the same way. The polymers behind them are covered in our article on PDO, PDLA and PCL.

The final three rows are the ones most often mistreated with injectables, and the most common source of money spent without the concern improving.

Routine effects — bruising, swelling, tenderness, temporary asymmetry — are common and settle. The complication that matters most is rare but serious: injection into or compression of a blood vessel, which can compromise the blood supply to skin or, very rarely, the eye.

Questions that indicate a safe practice

• Who is injecting, and what is their medical qualification?
• Is hyaluronidase kept on site, and can they say so without checking?
• What exactly is being injected — product name, not category?
• Is the product genuine and appropriately sourced?
• What is the plan if a complication occurs after hours?

The hyaluronidase question is a genuinely useful filter. Any clinic injecting HA should have it immediately available, because the window in which it helps a vascular occlusion is short.

Almost nobody sets out to look overfilled. It happens incrementally: each session adds a small amount, the change is gradual enough that the face becomes the new normal, and adaptation makes further volume seem necessary rather than excessive.

Two habits protect against it. Photograph yourself in consistent lighting before treatment starts, so comparison is against your own earlier face rather than your memory of it. And treat any suggestion of a fixed top-up schedule with scepticism — assessment of what remains should precede adding more, particularly given how long some filler persists.

Good injectable planning starts with facial anatomy, medical history and the patient's actual priority. Risks include bruising, swelling, asymmetry, infection and, rarely, vascular complications that can be serious. The safest plan is not necessarily the one with the most syringes or products.

Declare pregnancy or breastfeeding, autoimmune conditions, anticoagulants, previous injectable reactions or nodules, cold sore history if treating around the mouth, and any planned dental work or vaccination, since these can affect timing.